| Cancer radioimmunotherapy with alpha-emitting nuclides O Couturier, S Supiot, M Degraef-Mougin, A Faivre-Chauvet, T Carlier, ... European journal of nuclear medicine and molecular imaging 32, 601-614, 2005 | 218 | 2005 |
| Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives N Lepareur, F Lacœuille, C Bouvry, F Hindré, E Garcion, M Chérel, ... Frontiers in medicine 6, 132, 2019 | 120 | 2019 |
| Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11 M Cherel, M Sorel, B Lebeau, S Dubois, JF Moreau, R Bataille, ... | 111 | 1995 |
| Radiolabeled antibodies for cancer imaging and therapy J Barbet, M Bardiès, M Bourgeois, JF Chatal, M Chérel, F Davodeau, ... Antibody Engineering: Methods and Protocols, Second Edition, 681-697, 2012 | 100 | 2012 |
| Syndecan-1 regulates the biological activities of interleukin-34 AI Segaliny, R Brion, E Mortier, M Maillasson, M Cherel, Y Jacques, ... Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1853 (5), 1010-1021, 2015 | 93 | 2015 |
| Antitumor immunity induced after α irradiation JB Gorin, J Ménager, S Gouard, C Maurel, Y Guilloux, A Faivre-Chauvet, ... Neoplasia 16 (4), 319-328, 2014 | 90 | 2014 |
| Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO—a selected review M Bourgeois, H Rajerison, F Guerard, M Mougin-Degraef, J Barbet, ... Nuclear Medicine Review 14 (2), 90-95, 2011 | 87 | 2011 |
| Overview of the most promising radionuclides for targeted alpha therapy: The “hopeful eight” R Eychenne, M Chérel, F Haddad, F Guérard, JF Gestin Pharmaceutics 13 (6), 906, 2021 | 81 | 2021 |
| Radioimmunoconjugates for the treatment of cancer F Kraeber-Bodéré, C Bodet-Milin, C Rousseau, T Eugène, A Pallardy, ... Seminars in oncology 41 (5), 613-622, 2014 | 79 | 2014 |
| 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma M Chérel, S Gouard, J Gaschet, C Saï-Maurel, F Bruchertseifer, ... Journal of Nuclear Medicine 54 (9), 1597-1604, 2013 | 79 | 2013 |
| Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor α-chain genes generate a fusion mRNA in normal cells … F Magrangeas, G Pitiot, S Dubois, E Bragado-Nilsson, M Cherel, S Jobert, ... Journal of Biological Chemistry 273 (26), 16005-16010, 1998 | 78 | 1998 |
| Validation of 213Bi-α Radioimmunotherapy for Multiple Myeloma O Couturier, A Faivre-Chauvet, IV Filippovich, P Thédrez, C Saï-Maurel, ... Clinical cancer research 5 (10), 3165s-3170s, 1999 | 77 | 1999 |
| Immuno-PET for clinical theranostic approaches C Bailly, PF Cléry, A Faivre-Chauvet, M Bourgeois, F Guérard, F Haddad, ... International journal of molecular sciences 18 (1), 57, 2016 | 75 | 2016 |
| Astatine standard redox potentials and speciation in acidic medium J Champion, C Alliot, E Renault, BM Mokili, M Chérel, N Galland, ... The Journal of Physical Chemistry A 114 (1), 576-582, 2010 | 75 | 2010 |
| Targeting tumor associated macrophages to overcome conventional treatment resistance in glioblastoma H Grégoire, L Roncali, A Rousseau, M Chérel, Y Delneste, P Jeannin, ... Frontiers in pharmacology 11, 368, 2020 | 70 | 2020 |
| Comparison of the biologic effects of MA5 and B‐B4 monoclonal antibody labeled with iodine‐131 and bismuth‐213 on multiple myeloma S Supiot, A Faivre‐Chauvet, O Couturier, MF Heymann, N Robillard, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 69 | 2002 |
| Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma M Gérard, A Corroyer-Dulmont, P Lesueur, S Collet, M Chérel, ... Frontiers in medicine 6, 117, 2019 | 67 | 2019 |
| Mechanisms of cell sensitization to α radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines S Supiot, S Gouard, J Charrier, C Apostolidis, JF Chatal, J Barbet, ... Clinical cancer research 11 (19), 7047s-7052s, 2005 | 67 | 2005 |
| Cell tracking in cancer immunotherapy J Perrin, M Capitao, M Mougin-Degraef, F Guérard, A Faivre-Chauvet, ... Frontiers in medicine 7, 34, 2020 | 61 | 2020 |
| Tumor immunotargeting using innovative radionuclides F Kraeber-Bodéré, C Rousseau, C Bodet-Milin, C Mathieu, F Guérard, ... International journal of molecular sciences 16 (2), 3932-3954, 2015 | 61 | 2015 |
